Načítá se...
Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis
The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) includes representatives from advocacy organizations, Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institute of Neurological Disorders and Stroke (NINDS), academic institutions, and industry partners along...
Uloženo v:
| Vydáno v: | Mult Scler |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5405807/ https://ncbi.nlm.nih.gov/pubmed/28206828 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458517690823 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|